BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Australia's Paradigm Biopharmaceuticals reports positive early osteoarthritis drug trial results

Australian repurposing drug company Paradigm Biopharmaceuticals says positive clinical trial results for its osteoarthritis drug candidate indicate a poten...

October 07, 2022 | News

Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services

New 2,700-square-meter facility expands production capacity for monoclonal antibodies (mAbs) and other recombinant proteins Clients benefit from differe...

October 05, 2022 | News

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™

Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...

September 30, 2022 | News

Emmes (CRO) Acquires Clinical Edge

- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...

September 30, 2022 | News

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

WuXi STA, a leading global Contract Research Development and Manufacturing Organization (CRDMO), today announced the opening of its first high potency (HP)...

September 27, 2022 | News

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

This research was jointly conducted with Prof. Wernig at Sanford University and Prof. Rowitch at UCSF. The research was published in the online edition of ...

September 21, 2022 | News

Rapid growth puts Australian CRO Accelagen on the map for clinical research globally

Accelagen, one of Australia's leading Contract Research Organisations, has taken new 472sqM office space in Hawthorn East following two year...

September 20, 2022 | News

Redbud raises $10M in series A round as CRO focusing on science-driven clinical development

Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...

September 13, 2022 | News

WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility

WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...

September 12, 2022 | News

Catalent Expands Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

The investment will increase the site’s footprint by nearly 20% to 31,000 square feet, and allow the installation of 35 new freezers for ultra-low ...

September 07, 2022 | News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...

September 05, 2022 | News

WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility

The site's clinical manufacturing operations have an initial capacity of 4,000L and will grow to 6,000L, utilizing only single-use technology, adding to th...

September 01, 2022 | News

Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs

This strategic collaboration will further integrate the resources and capabilities of both parties, jointly promote the establishment of microbial vec...

August 30, 2022 | News

Liminal BioSciences Announces Termination of Legacy CDMO Contract

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a development-stage biopharmaceutical company, announced today that,...

August 26, 2022 | News

Stay Connected